Important note: Before prescribing, consult full prescribing information.
Presentation: Dispersible tablets containing 125 mg, 250 mg or 500 mg of deferasirox.
Indications: For the treatment of chronic iron overload due to frequent blood transfusions (≥7 ml/kg/month of packed red blood cells) in patients with beta-thalassemia major aged 6 years and older.
Monthly monitoring of serum ferritin to assess patient's response to therapy
Maximum daily dose is 40 mg/kg body weight.
Monthly monitoring of serum ferritin
Maximum daily dose is 20 mg/kg body weight.
Legal Category: country specific
Packs: country specific information
This medical product is subject to additional monitoring.
This will allow quick identification of new safety information.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system.